15 patents
Utility
LSD1 inhibitors and medical uses thereof
10 Jan 23
Francois Brucelle, Victor S. Gehling, Avinash Khanna
Filed: 27 Apr 21
Utility
Modulators of methyl modifying enzymes, compositions and uses thereof
4 Oct 22
Jehrod B. Brenneman, Alexandre Côté, Victor S. Gehling, Avinash Khanna, Julian R. Levell, Ludivine Moine
Filed: 8 Nov 18
Utility
P300/CBP hat inhibitors
16 Aug 22
Jonathan E. Wilson, Julian R. Levell
Filed: 15 Feb 19
Utility
P300/CBP HAT inhibitors
15 Mar 22
Jonathan E. Wilson, Francois Brucelle, Julian R. Levell
Filed: 15 Feb 19
Utility
Modulators of methyl modifying enzymes, compositions and uses thereof
15 Mar 22
Alexandre Côté, Victor S. Gehling, Avinash Khanna, Ludivine Moine, Jacob I. Stuckey
Filed: 23 Apr 20
Utility
Therapeutic compounds and uses thereof
15 Feb 22
Patrick Cyr, Sarah Bronner, F. Anthony Romero, Steven Magnuson, Vickie Hsiao-Wei Tsui, Jeremy M. Murray, John Wai, Kwong Wah Lai, Fei Wang, Kevin X. Chen
Filed: 21 Nov 18
Utility
Therapeutic compounds and uses thereof
9 Nov 21
Patrick Cyr, Sarah Bronner, F. Anthony Romero, Steven Magnuson, Vickie Hsiao-Wei Tsui, John Wai, Kwong Wah Lai, Fei Wang
Filed: 28 May 20
Utility
LSD1 inhibitors and medical uses thereof
25 May 21
Francois Brucelle, Victor S. Gehling, Avinash Khanna
Filed: 1 Nov 19
Utility
Methods of treating myeloproliferative disorders
16 Feb 21
The present disclosure relates to the use of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide, and pharmaceutically acceptable salts thereof, for treating myelofibrosis.
Adrian Senderowicz, Michael Cooper
Filed: 7 Oct 20
Utility
Therapeutic compounds and uses thereof
29 Jun 20
Patrick Cyr, Sarah Bronner, F. Anthony Romero, Steven Magnuson, Vickie Hsiao-Wei Tsui, John Wai, Kwong Wah Lai, Fei Wang
Filed: 20 Nov 18
Utility
Modulators of methyl modifying enzymes, compositions and uses thereof
22 Jun 20
Alexandre Côté, Victor S. Gehling, Avinash Khanna, Ludivine Moine, Jacob I. Stuckey
Filed: 17 Apr 19
Utility
Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide
2 Mar 20
Brian K. Albrecht, Alisha Arrigo, Donald Corson, Victor S. Gehling, Bruno Patrice Haché, Jean-Christophe Harmange, Jonathan Lane
Filed: 24 Aug 16
Utility
LSD1 inhibitors and uses thereof
6 Jan 20
Brian K. Albrecht, James Edmund Audia, Alexandre Côté, Martin Duplessis, Victor S. Gehling, Jean-Christophe Harmange, Rishi G. Vaswani
Filed: 21 Apr 16
Utility
LSD1 inhibitors and medical uses thereof
30 Dec 19
Francois Brucelle, Victor S. Gehling, Avinash Khanna
Filed: 25 Oct 17
Utility
Synthesis of inhibitors of EZH2
28 Oct 19
Provided herein are synthetic methods for the preparation of EZH2 inhibitors.
Rishi G. Vaswani, Michael Charles Hewitt
Filed: 17 Oct 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first